SCHEMBL3723935

SCHEMBL3723935

O=C(O)N1CCC(N(c2ccccc2)S(=O)(=O)c2ccc(-c3ccccc3)cc2)CC1.O=C(O)N1CC[C@H](N(c2ccccc2)S(=O)(=O)c2ccc3ccccc3c2)CC1CCCN(Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MCL1 Q07820 3/20 0.39
▸ BCL2L1 Q07817 1/20 0.39
▸ PTGES O14684 3/20 0.36
▸ ALOX5 P09917 3/20 0.36
▸ HTR2A P28223 3/20 0.36
▸ HTR2C P28335 3/20 0.36
▸ HTR7 P34969 3/20 0.36
▸ DRD3 P35462 2/20 0.36
▸ HTR1A P08908 1/20 0.36
▸ HTR6 P50406 1/20 0.36
▸ ESR1 P03372 1/20 0.34
▸ CCR4 P51679 3/20 0.34
▸ DRD2 P14416 1/20 0.34
▸ SLC6A2 P23975 1/20 0.33
▸ SLC6A4 P31645 1/20 0.33
▸ SLC6A3 Q01959 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ ITGB3 P05106 1/20 0.33
▸ ITGA2B P08514 1/20 0.33
▸ F2 P00734 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3726385 0.85 MEN1 (0.41) —
SCHEMBL4783965 0.83 CHRM2 (0.44) OPRD1
SCHEMBL3722537 0.82 OPRM1 (0.39) HTR2AHTR2C
SCHEMBL3724780 0.79 TAS2R14 (0.44) PTGESHTR2AHTR2CHTR7
SCHEMBL3806319 0.76 CHRM5 (0.36) PTGESALDH1A1
SCHEMBL3727160 0.75 RORC (0.38) HTR2AHTR2CKCNH2ALDH1A1
SCHEMBL3728078 0.74 HTR7 (0.37) HTR2AHTR2CHTR7HTR6ALDH1A1
SCHEMBL13985631 0.74 MMP8 (0.43) MCL1PTGESALOX5HTR2AHTR2C
SCHEMBL3724470 0.73 HTR2A (0.37) HTR2AHTR2CKCNH2
SCHEMBL3725056 0.73 HSD11B1 (0.42) HTR2AHTR2CDRD3HTR1AHTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155676-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS Commissariat à l'Energie Atomique (FR) 2010-02-24 — — EP disclosed
WO-2008146172-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2008-12-04 — — WO disclosed
Send feedback